Fulgent Genetics Inc FLGT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
-
Fulgent Presents Updated FID-007 Data at ASCO 2026
-
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting
-
Fulgent Reports First Quarter 2026 Financial Results
-
Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting
Trading Information
- Previous Close Price
- $19.61
- Day Range
- $19.45–19.93
- 52-Week Range
- $13.46–31.04
- Bid/Ask
- $19.60 / $20.00
- Shares Outstanding
- 28.40M
- Market Cap
- $564.60M
- Volume/Avg
- 299,560 / 436,106
Key Statistics
- Price/Earnings (Normalized)
- 47.08
- Price/Sales
- 1.88
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 8.55%
Company Profile
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,315
- Website
- https://www.fulgentgenetics.com
Valuation
|
Metric
|
FLGT
|
|---|---|
Price/Earnings (Normalized) | 48.40 |
Price/Book Value | 0.55 |
Price/Sales | 1.94 |
Price/Cash Flow | 637.29 |
Price/Earnings
FLGT
Financial Strength
|
Metric
|
FLGT
|
|---|---|
Quick Ratio | 3.91 |
Current Ratio | 5.31 |
Interest Coverage | −1,484.03 |
Quick Ratio
FLGT
Profitability
|
Metric
|
FLGT
|
|---|---|
Return on Assets (Normalized) | 0.06% |
Return on Equity (Normalized) | 0.07% |
Return on Invested Capital (Normalized) | −2.46% |
Return on Assets
FLGT
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|yXymr>m | LOCK|B$ | $198B | |||
| Danaher Corp
DHR
| LOCK|Fv!?<w%@ | LOCK|vP | $144B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|yqQ>$<!x | LOCK|Kk | $45B | |||
| Agilent Technologies Inc
A
| LOCK|v!VDMR> | LOCK|#r | $37B | |||
| Waters Corp
WAT
| LOCK|#$S#q% | LOCK|RQ | $36B | |||
| IQVIA Holdings Inc
IQV
| LOCK|F!!G^@> | LOCK|d<vmn | $34B | |||
| Illumina Inc
ILMN
| LOCK|v?!<m> | LOCK|vgkBt | $28B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|G<%XVMN | LOCK|>p<V | $26B | |||
| Quest Diagnostics Inc
DGX
| LOCK|^x>mKY@ | LOCK|!jX? | $23B | |||
| Labcorp Holdings Inc
LH
| LOCK|%q@Bclt | LOCK|hXV< | $23B |
United States